Company Uses Patients ' Own Cells To Put An End To Baldness, Aging Skin And Tendon Degeneration

A Canadian company has developed first-of-their-kind cell therapies that will, they hope, treat conditions that now affect 1 in 3 Americans: pattern baldness, aging and sun-damaged skin, and chronic tendon degeneration.

Source: Forbes.com Healthcare News - September 29, 2017 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news